A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q3Scopus Q1KCI Q2
- 저널
- GUT AND LIVER17(2) · pp.226 · 2023
- 피인용
- Web of Science 4Scopus 5KCI 1
- FWCI (Scopus)
- 0.31
- JCR IF
- JCR 2022 3.4
- ISSN
- 1976-2283
저자
- Park, Su Hyun제1저자Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
- Lee, Kang NyeongHanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
- Lee, Oh Young교신저자Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
- Choi, Myung GyuCatholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea
- Kim, Jie-HyunGangnam Severance Hosp, Dept Internal Med, Seoul, South Korea
- Sung, In-KyungKonkuk Univ, Dept Internal Med, Coll Med, Seoul, South Korea
- Jang, Jae YoungKyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea
- Park, Kyung SikKeimyung Univ, Dept Internal Med, Coll Med, Daegu, South Korea
- Chun, Hoon JaiKorea Univ Anam Hosp, Dept Internal Med, Seoul, South Korea
- Kim, Eun YoungDaegu Catholic Univ, Sch Med, Dept Internal Med, Daegu, South Korea
- Lee, Jun KyuDongguk Univ, Ilsan Hosp, Coll Med, Dept Internal Med, Goyang, South Korea
- Jang, Jin SeokDong A Univ, Dong A Univ Hosp, Coll Med, Dept Internal Med, Busan, South Korea
- 김광하Pusan Natl Univ, Dept Internal Med, Sch Med, Busan, South Korea
- Hong, Su JinSoonchunhyang Univ, Coll Med, Dept Internal Med, Bucheon, South Korea
- Lee, Yong ChanYonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul, South Korea
- Choi, Suck-CheiWonkwang Univ, Coll Med, Dept Internal Med, Iksan, South Korea
- Kim, Hyun SooYonsei Univ, Wonju Coll Med, Wonju Severance Christian Hosp, Dept Internal Med, Wonju, South Korea
- Kim, Tae OhInje Univ, Haeundae Paik Hosp, Dept Internal Med, Busan, South Korea
- Baik, Gwang HoHallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Internal Med, Chunchon, South Korea
- Jeon, Yong CheolHanyang Univ, Guri Hosp, Coll Med, Dept Internal Med, Guri, South Korea
초록
Background/Aims: Efficacy of proton pump inhibitors is limited in patients with nonerosive reflux disease (NERD). The aim of this study was to comparatively evaluate the efficacy and safety of esomeprazole with sodium bicarbonate and esomeprazole alone. Methods: This was a multicenter, randomized, double-blind, active-controlled, noninferiority comparative study. A total of 379 patients with NERD were randomly allocated to receive either EsoduoⓇ (esomeprazole 20 mg with sodium bicarbonate 800 mg) or NexiumⓇ (esomeprazole 20 mg) once daily for 4 weeks from January 2019 to December 2019. The patients had a history of heartburn for at least 2 days in the week before randomization as well as in the last 3 months and no esophageal mucosal breaks on endoscopy. The primary endpoint was a complete cure of heartburn at week 4. The secondary and exploratory endpoints as well as the safety profiles were compared in the groups at weeks 2 and 4. Results: A total of 355 patients completed the study (180 in the EsoduoⓇ group and 175 in the NexiumⓇ group). The proportions of patients without heartburn in the entire 4th week of treatment were not different between the two groups (33.33% in the EsoduoⓇ group and 35% in the NexiumⓇ group, p=0.737). There were no significant differences in most of the secondary and exploratory endpoints as well as the safety profiles. Conclusions: EsoduoⓇ is as effective and safe as NexiumⓇ for managing typical symptoms in patients with NERD (ClinicalTrial.gov identifier: NCT03928470).
키워드
EsomeprazoleGastroesophageal refluxPhase IV clinical trialSodium bicarbonate
식별자
- Scopus EID
- 2-s2.0-85150311636
- WoS UID
- 001177148000006
- KCI
- ART002940897



로그인
연구물 목록으로